Results 41 to 50 of about 2,315 (156)

Re-Expression of Tafazzin Isoforms in TAZ-Deficient C6 Glioma Cells Restores Cardiolipin Composition but Not Proliferation Rate and Alterations in Gene Expression

open access: yesFrontiers in Genetics, 2022
Tafazzin—an acyltransferase—is involved in cardiolipin (CL) remodeling. CL is associated with mitochondrial function, structure and more recently with cell proliferation. Various tafazzin isoforms exist in humans.
Gayatri Jagirdar   +11 more
doaj   +1 more source

Effects of N‐oleoylethanolamide on Lymphoblasts Deficient in Tafazzin

open access: yesThe FASEB Journal, 2021
Barth Syndrome (BTHS) is a rare X‐linked genetic disorder caused by mutations in the TAZ gene that encodes for the cardiolipin remodelling enzyme, Tafazzin. This syndrome is characterized by cardiac and skeletal myopathies, as well as immunological deficits that cause significant morbidity ...
John Chan   +6 more
openaire   +1 more source

Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency [PDF]

open access: yesBiochemistry, 2018
Tafazzin is the mitochondrial enzyme that catalyzes transacylation between a phospholipid and a lysophospholipid in remodeling. Mutations in tafazzin cause Barth syndrome, a potentially life-threatening disease with the major symptom being cardiomyopathy.
Tomohiro Kimura   +6 more
openaire   +2 more sources

Barth syndrome mutations that cause tafazzin complex lability [PDF]

open access: yesJournal of Cell Biology, 2011
Deficits in mitochondrial function result in many human diseases. The X-linked disease Barth syndrome (BTHS) is caused by mutations in the tafazzin gene TAZ1. Its product, Taz1p, participates in the metabolism of cardiolipin, the signature phospholipid of mitochondria.
Claypool, Steven M   +4 more
openaire   +4 more sources

Mouse Tafazzin Is Required for Male Germ Cell Meiosis and Spermatogenesis [PDF]

open access: yesPLOS ONE, 2015
Barth syndrome is an X-linked mitochondrial disease, symptoms of which include neutropenia and cardiac myopathy. These symptoms are the most significant clinical consequences of a disease, which is increasingly recognised to have a variable presentation.
Cadalbert, L.C.   +6 more
openaire   +5 more sources

Tafazzin knockdown in murine mesenchymal stem cells enhances the tafazzin knockdown mediated elevation in interleukin-10 secretion from murine B lymphocytes

open access: yesArchives of Microbiology & Immunology, 2023
Abstract Barth Syndrome is a rare X-linked genetic disorder caused by mutations in the TAFAZZIN gene. We recently demonstrated that tafazzin (Taz) protein deficiency in murine mesenchymal stems (MSCs) reduces immune function of activated wild type (WT) B lymphocytes. Interleukin-10 (
Hana M. Zegallai   +2 more
openaire   +1 more source

Tafazzin Modulates Allergen-Induced Mast Cell Inflammatory Mediator Secretion [PDF]

open access: yesImmunoHorizons, 2021
Abstract Allergic inflammatory diseases are a steadily growing health concern. Mast cells, a driving force behind allergic pathologies, modulate metabolic pathways to carry out various functions following IgE-FcεRI–mediated activation. Tafazzin (TAZ) is a cardiolipin transacylase that functions to remodel, and thereby mature, cardiolipin,
Aindriu R R Maguire   +6 more
openaire   +2 more sources

Defective Mitochondrial Cardiolipin Remodeling Dampens HIF-1α Expression in Hypoxia

open access: yesCell Reports, 2018
Summary: Mitochondria fulfill vital metabolic functions and act as crucial cellular signaling hubs, integrating their metabolic status into the cellular context.
Arpita Chowdhury   +17 more
doaj   +1 more source

Phenotypic Characterization of Male Tafazzin-Knockout Mice at 3, 6, and 12 Months of Age

open access: yesBiomedicines, 2023
Barth syndrome (BTHS) is an X-linked mitochondrial disease caused by mutations in the gene encoding for tafazzin (TAZ), a key enzyme in the remodeling of cardiolipin.
Michelle V. Tomczewski   +4 more
doaj   +1 more source

AAV9-TAZ Gene Replacement Ameliorates Cardiac TMT Proteomic Profiles in a Mouse Model of Barth Syndrome

open access: yesMolecular Therapy: Methods & Clinical Development, 2019
Barth syndrome (BTHS) is a rare mitochondrial disease that causes severe cardiomyopathy and has no disease-modifying therapy. It is caused by recessive mutations in the gene tafazzin (TAZ), which encodes tafazzin—an acyltransferase that remodels the ...
Silveli Suzuki-Hatano   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy